Real‐World Long‐Term Outcomes of Operated and Non‐Operated Rectal Cancer in the Elderly: A 14‐Year Retrospective Multicentre Study
- 9 June 2025
- journal article
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
Abstract
Objective: Surgical resection is the cornerstone of rectal cancer treatment. Following neoadjuvant chemoradiotherapy (nCRT), many patients undergo surgery. Another group of patients may not undergo surgery for various reasons, regardless of nCRT response. This study investigates the differences in clinical characteristics and long‐term oncological outcomes of operated and non‐operated elderly rectal cancer patients.Methods: This multicentre observational retrospective cohort analysis included 296 elderly patients (169 surgery, 127 non‐surgical) treated at three tertiary cancer centres in Turkey between January 2010 and April 2024. Clinicopathologic features and survival outcomes were compared between groups.Results: Patients in the surgery group were younger (p < 0.000) and had better performance scores (p < 0.000). There were no differences in initial clinical (c) T stages or cM stages; however, cN2 patients were more prevalent in the surgical group and cN1 patients were more prevalent in the non‐surgical group (p = 0.010). No differences in radiotherapy treatment schedules were observed among the groups. The surgical group received more concurrent (p = 0.046) and adjuvant (p < 0.000) chemotherapy. Patient refusal (63.8%) was the most common reason among non‐surgical patients. The surgery group showed better overall survival (OS) (median, 99 vs. 33 months) (p < 0.000), local recurrence‐free survival (LRFS) (97.8% vs. 65.8% at 3 years, p < 0.000), and distant metastasis‐free survival (DMFS) (80.3% vs. 73.3% at 3 years, p = 0.022).Conclusion: This study shows that elderly rectal cancer patients without surgery had poor survival and tumour control. Surgical resection in rectal cancer is very important and should be strongly recommended for all medically suitable elderly patients.Keywords
This publication has 19 references indexed in Scilit:
- Oncological risks associated with the planned watch-and-wait strategy using total neoadjuvant treatment for rectal cancer: A narrative reviewCancer Treatment Reviews, 2024
- Radiotherapy dose escalation using endorectal brachytherapy in elderly and frail patients with rectal cancer unsuitable for surgery: Lessons from studies in fit patients and future perspectivesCancer Treatment Reviews, 2022
- Organ Preservation in Rectal Cancer: An Overview of the Dutch Perspective and Recent DevelopmentsClinical Oncology, 2022
- Clinical Complete Response in Patients With Rectal Adenocarcinoma Treated With Short-Course Radiation Therapy and Nonoperative ManagementInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2022
- Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trialThe Lancet Oncology, 2021
- Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trialThe Lancet Oncology, 2021
- Tumor response after long interval comparing 5x5Gy radiation therapy with chemoradiation therapy in rectal cancer patientsEuropean Journal of Surgical Oncology, 2018
- Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient dataThe Lancet Oncology, 2010
- Rectal cancer surgery: A brief historySurgical Oncology, 2010
- AJCC Cancer Staging Manual2010